In individuals with pancreatic ductal adenocarcinoma (PDA), Src expression and activation have been found to be increased in 75% and 60% of tumors, respectively (Lutz et al., 1998; Morton et al., 2010). Here, SRC is linked to Patent ductus arteriosus.